1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone has been researched along with Astrocytoma, Grade IV in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Ito, H; Izumi, H; Kuwano, M; Miyamoto, T; Murakami, Y; Nakahara, Y; Ono, M; Shibata, T; Wakimoto, H; Watari, K | 1 |
1 other study(ies) available for 1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Female; Glioblastoma; Glycogen Synthase Kinase 3 beta; Hexanones; Humans; Intracellular Signaling Peptides and Proteins; Kaplan-Meier Estimate; Male; Middle Aged; Phosphorylation; Primary Cell Culture; Prognosis; Protein Stability; Pyridines; Pyrimidines; RNA, Small Interfering; Signal Transduction; Thiadiazoles; Xenograft Model Antitumor Assays | 2020 |